1. Sato S, Hirakata M, Kuwana M, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum, 2005, 52:1571-1576.
[2]
2. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med, 1975, 292:344-347.
[3]
3. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med, 2002, 165:277-304.
[4]
4. Mills ES, Mathews WH. Interstitial pneumonitis in dermatomyositis. J Am Med Assoc, 1956, 160:1467-1470.
[5]
5. Marie I, Hachulla E, Chérin P, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum, 2002, 47:614-622.
[6]
9. Chua F, Higton AM, Colebatch AN, et al. Idiopathic inflammatory myositis-associated interstitial lung disease:ethnicity differences and lung function trends in a British cohort. Rheumatology (Oxford), 2012, 51:1870-1876.
[7]
11. Kameda H, Nagasawa H, Ogawa H, et al. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol, 2005, 32:1719-1726.
[8]
15. Suh GY, Kang EH, Chung MP, et al. Early intervention can improve clinical outcome of acute interstitial pneumonia. Chest, 2006, 129:753-761.
[9]
6. Chen IJ, Jan WYJ, Lin CW, et al. Interstitial lung disease in polymyositis and dermatomyositis. Clin Rheumatol, 2009, 28:639-646.
[10]
7. Richards TJ, Eggebeen A, Gibson K, et al. Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease. Arthritis Rheum, 2009, 60:2183-2192.
16. Marie I, Hachulla E, Chérin P, et al. Opportunistic infections in polymyositis and dermatomyositis. Arthritis Rheum, 2005, 53:155-165.
[17]
17. Kono H, Inokuma S, Nakayama H, et al. Pneumomediastinum in dermatomyositis:association with cutaneous vasculopathy. Ann Rheum Dis, 2000, 59:372-376.
